Starboard has accused Pfizer of “coercive conduct” after executives who initiall...
Booster Therapeutics has announced its inception to develop a new class of prote...
KeyBioscience and Eli Lilly have extended their partnership to develop a new cla...
High-concentration monoclonal antibodies (mAbs) are gaining prominence given the...
Imuldosa is the latest FDA-approved biosimilar of J&J’s blockbuster therapy for ...
The Cardiovascular and Renal Drugs Advisory Committee voted 10-6 in support of S...
Plaque psoriasis is a chronic condition that affects millions yet is often misun...
The US FDA approved Itovebi in combination with Pfizer’s Ibrance and AstraZeneca...
City Therapeutics has announced its launch accompanied by a $135m Series A finan...
Ipsen has received the UK MHRA's approval for its Elafibranor (Iqirvo) for the t...
In this issue: The manufacturing shift to meet growing cell and gene therapy dem...
Emergent said it is separately working on increasing the availability of its ove...
As a major report highlights the challenges of a struggling NHS, the call for pr...
The US FDA has declined to approve Zealand Pharma's dasiglucagon for hypoglycaem...
Purespring Therapeutics has raised $105m in a Series B funding round which will ...
